Home › Research › Digital health tools
Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis
Cote AC, Phelps RJ, Kabiri NS, Bhangu JS, Thomas KK.. Frontiers in medicine, 2021-01-11
Topic: Risk, prevention and care in population studies
Plain-language summary
Forty-eight studies from 18,456 screened abstracts (Dementia: n = 2,516, Control: n = 1,224) met inclusion criteria for the systematic review. Nineteen of these studies were included in one or multiple meta-analyses (Dementia: n = 617, Control: n = 406). Participants with dementia demonstrated lower levels of daily activity (standardized mean difference (SMD), -1.60; 95% CI, -2.66 to -0.55), decreased sleep efficiency (SMD, -0.52; 95% CI, -0.89 to -0.16), and greater intradaily circadian variability (SMD, 0.46; 95% CI, 0.27 to 0.65) than controls, among other measures. Statistical between-study heterogeneity was observed, possibly due to variation in testing duration, device type or patient setting. Conclusions and Relevance: Digitally captured data using wearable devices revealed that adults with dementia were less active, demonstrated increased fragmentation of their sleep-wake cycle and a loss of typical diurnal variation in circadian rhythm as compared to controls.
What this study adds
Evidence grade: High
This is a pooled review of 2,516 participants. This review and meta-analysis found that adults with dementia were less active, had decreased sleep efficiency, and greater circadian variability than controls, based on wearable device data. It describes monitoring findings, not a treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cote, A. C., Phelps, R. J., Kabiri, N. S., Bhangu, J. S., & Thomas, K. K. (2020). Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis. Frontiers in medicine. https://doi.org/10.3389/fmed.2020.501104
Vancouver
Cote AC, Phelps RJ, Kabiri NS, Bhangu JS, Thomas KK. Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis. Frontiers in medicine. 2020. doi:10.3389/fmed.2020.501104. PMID: 33505979.
BibTeX
@article{cote2020-33505979,
author = {Cote, A. C. and Phelps, R. J. and Kabiri, N. S. and Bhangu, J. S. and Thomas, K. K.},
title = {{Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis}},
journal = {Frontiers in medicine},
year = {2020},
doi = {10.3389/fmed.2020.501104},
pmid = {33505979},
url = {https://doi.org/10.3389/fmed.2020.501104}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Forty-eight studies from 18,456 screened abstracts (Dementia: n = 2,516, Control: n = 1,224) met inclusion criteria for the systematic review.
- Nineteen of these studies were included in one or multiple meta-analyses (Dementia: n = 617, Control: n = 406).
- Participants with dementia demonstrated lower levels of daily activity (standardized mean difference (SMD), -1.60; 95% CI, -2.66 to -0.55), decreased sleep efficiency (SMD, -0.52; 95% CI, -0.89 to -0.16), and greater intradaily circadian variability (SMD, 0.46; 95% CI, 0.27 to 0.65) than controls, among other measures.
- Statistical between-study heterogeneity was observed, possibly due to variation in testing duration, device type or patient setting.
- Conclusions and Relevance: Digitally captured data using wearable devices revealed that adults with dementia were less active, demonstrated increased fragmentation of their sleep-wake cycle and a loss of typical diurnal variation in circadian rhythm as compared to controls.
Why it matters
This review and meta-analysis found that adults with dementia were less active, had decreased sleep efficiency, and greater circadian variability than controls, based on wearable device data. It describes monitoring findings, not a treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Study designsystematic review
- Participants2,516
- Evidence strengthHigh
How this study scored 64/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for effect reported because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 61 of the 96 points we could judge it on, which is 64 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in medicine) |
| Journal's citation record | 1 / 4 | Frontiers in Medicine: journal h-index 149 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 3 / 4 | 2,516 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 4 / 7 | Cited 58 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 7.2 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 2 / 6 | Cited 2.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 40 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Kevin “Kip” Thomas holds only 3 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 1 / 3 | Boston University: institution h-index 1,456 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33505979) |
| Free to read | 2 / 2 | Free to read |
| Points | 61 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 61 of the 96 points we could judge it on is 64 out of 100. |
| Total | 64 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fmed.2020.501104
- PubMed: 33505979
- Original source →
- Free full text: Frontiers in Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Digital health tools from nearby years
Also tagged “prevalence”
1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.